Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Kountouras, Jannis [Clear All Filters]
Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al..
Obes Surg. 32(6), 2079-2080.
(2022). Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease..
Metabolism. 135, 155276.
(2022). Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology..
J Gastrointest Cancer.
(2022). Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes..
Am J Hypertens.
(2022). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022). Association between Infection and Nasal Polyps: A Systematic Review and Meta-Analysis..
Microorganisms. 11(6),
(2023). Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome..
J Neurogastroenterol Motil. 29(3), 403-404.
(2023). Controlling the Impact of -Related Hyperhomocysteinemia on Neurodegeneration..
Medicina (Kaunas). 59(3),
(2023). Impact of nonalcoholic fatty liver disease-related metabolic state on depression..
Neurochem Int. 163, 105484.
(2023). Innate immunity and nonalcoholic fatty liver disease..
Ann Gastroenterol. 36(3), 244-256.
(2023). Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities..
Aliment Pharmacol Ther. 57(10), 1186-1187.
(2023). Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels..
Aliment Pharmacol Ther. 58(11-12), 1252-1253.
(2023). Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?.
Curr Vasc Pharmacol.
(2023). Nonalcoholic fatty liver disease test: an external validation cohort..
Hormones (Athens).
(2023). Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B..
J Viral Hepat.
(2023). Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease..
Clin Immunol. 256, 109776.
(2023). Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications..
Hepatobiliary Pancreat Dis Int.
(2023).
(2024).